tiprankstipranks
Trending News
More News >
Crinetics Pharma (CRNX)
:CRNX
US Market
Advertisement

Crinetics Pharmaceuticals (CRNX) Technical Analysis

Compare
555 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
4Neutral
6Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Crinetics Pharma’s (CRNX) Moving Averages Convergence Divergence (MACD) indicator is 0.36, suggesting Crinetics Pharma is a Sell.
Crinetics Pharma’s (CRNX) 20-Day exponential moving average is 31.24, while Crinetics Pharma’s (CRNX) share price is $31.9, making it a Buy.
Crinetics Pharma’s (CRNX) 50-Day exponential moving average is 31.40, while Crinetics Pharma’s (CRNX) share price is $31.9, making it a Buy.

Crinetics Pharmaceuticals (CRNX) Pivot Points

Jul 20, 2025, 02:10 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
30.14
30.80
31.35
32.01
32.56
33.22
33.77
Fibonacci
30.80
31.26
31.55
32.01
32.47
32.76
33.22
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crinetics Pharmaceuticals (CRNX) Moving Averages

Jul 20, 2025, 02:10 AM
Period
Simple
Exponential
MA5
32.34Buy
32.24Buy
MA10
31.42Buy
31.68Buy
MA20
30.64Buy
31.24Buy
MA50
31.08Buy
31.40Buy
MA100
31.79Buy
33.45Sell
MA200
41.05Sell
40.37Sell
Crinetics Pharma’s (CRNX) 10-Day exponential moving average is 31.68, while Crinetics Pharma’s (CRNX) share price is $31.9, making it a Buy.
Crinetics Pharma’s (CRNX) 100-Day exponential moving average is 33.45, while Crinetics Pharma’s (CRNX) share price is $31.9, making it a Sell.
Crinetics Pharma’s (CRNX) stock price is $31.9 and Crinetics Pharma’s (CRNX) 50-day simple moving average is 31.08, creating a Buy signal.
Crinetics Pharma’s (CRNX) stock price is $31.9 and Crinetics Pharma’s (CRNX) 100-day simple moving average is 31.79, creating a Buy signal.
Crinetics Pharma’s (CRNX) stock price is $31.9 and Crinetics Pharma’s (CRNX) 200-day simple moving average is 41.05, creating a Sell signal.

Crinetics Pharmaceuticals (CRNX) Technical Indicators

Jul 20, 2025, 02:10 AM
Name
Value
Implied Action
RSI (14)
60.06
Neutral
STOCH (9,6)
73.88
Neutral
STOCHRSI (14)
75.92
Neutral
MACD (12,26)
0.36
Sell
ADX (14)
19.43
Buy
Williams %R
-9.13
Sell
CCI (14)
129.35
Sell
ATR (14)
1.35
-
Ultimate Oscillator
58.63
Neutral
ROC
10.10
Buy
Crinetics Pharma’s (CRNX) Relative Strength Index (RSI) is 60.06, creating a Neutral signal.
Crinetics Pharma’s (CRNX) Trend Strength Indicator (ADX) is 19.43, creating a Buy signal.
Crinetics Pharma’s (CRNX) Commodity Channel Index (CCI) is 129.35, creating a Sell signal.
Crinetics Pharma’s (CRNX) Price Rate of Change (ROC) is 10.10, creating a Buy signal.

FAQ

Is CRNX a Buy, Hold, or Sell?
Based on CRNX’s technical indicators, CRNX is a Buy.
    What is CRNX’s RSI (14)?
    CRNX’s RSI (14) is 60.06, which suggests CRNX is a Neutral.
      What is CRNX’s MACD?
      CRNX’s MACD is 0.36, which suggests CRNX is a Sell.
        What is CRNX’s 5-day moving average?
        CRNX’s 5-day moving average is 32.34, which suggests CRNX is a Buy.
          What is CRNX’s 20-day moving average?
          CRNX 20-day moving average is 30.64, which suggests CRNX is a Buy.
            What is CRNX’s 50-day moving average?
            CRNX’s 50-day moving average is 31.08, which suggests CRNX is a Buy.
              What is CRNX’s 200-day moving average?
              CRNX’s 200-day moving average is 41.05, which suggests CRNX is a Sell.
                What is CRNX’s Williams % R (14)?
                CRNX’s Williams % R (14) is -9.13, which suggests CRNX is a Sell.
                  What is CRNX’s CCI (14)?
                  CRNX’s CCI (14) is 129.35, which suggests CRNX is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis